Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Complex PCI in high bleeding risk patients, the way forward!

07 Dec 2023 – From GulfPCR-GIM 2023

Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.

Complex PCI in high bleeding risk patients, the way forward!

How artificial intelligence can help in optimising PCI for treatment of complex lesions

06 Dec 2023 – From GulfPCR-GIM 2023

Watch this session with LIVE case to learn how artificial intelligence with OCT can simplify procedural strategy, and reduce operation time and contrast.
A 54-year-old male who underwent PPCI to distal RCA in 2019, presented with angina class II-III and positive TMT - stage II. The...

How artificial intelligence

A new angiographic tool to evaluate stent expansion besides intracoronary imaging

24 Nov 2023

A 57-year-old man with hypertension and dyslipidemia as cardiovascular risk factors was admitted for stable angina for months. His symptoms were not controlled despite maximal medical treatment (beta-blockers, nitrates, aspirin, statins). Angios revealed multivessel disease. How would you manage this case?

Author

Salvatore Brugaletta
3DStent: a new tool to evaluate stent expansion besides intra-coronary imaging

AHA 2023: get the interventional cardiology perspective!

11 Nov 2023

Stay up to date with what is new and hot in interventional cardiology at #AHA23 in Philadelphia.

PCRonline @ AHA 2023

Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

27 Oct 2023

Mirvat Alasnag provides her take on the AGENT IDE trial which was presented by Robert W. Yeh at TCT Congress 2023. This pivotal randomized trial compares the safety and efficacy of the AGENT DCB to conventional balloon angioplasty in patients with ISR. It is the first...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)

T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

26 Oct 2023

Ali Nazmi Calik interviews Myeong-Ki Hong about the results of the T-Pass randomised trial which he presented during the #TCT Congress 2023 in San Francisco.

Myeong-Ki Hong

Author

Myeong-Ki Hong

Author

Ali Nazmi Calik
T-PASS: Less than 1-month DAPT followed by ticagrelor monotherapy after DES Implantation for ACS

PCRonline @ TCT 2023 - Get the international perspective!

17 Oct 2023

Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!

PCRonline @ TCT 2023 - get the international perspective!

Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?

22 Sep 2023 – From AICT-AsiaPCR 2023

This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...

Leave nothing behind DCB-only PCI strategy evidence changed today practice

A hybrid approach in complex PCI: can DES and DCB be complementary?

21 Sep 2023 – From AICT-AsiaPCR 2023

Watch this case-based session to follow discussion about how to choose between DES & DCB,  how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.

A hybrid approach in

PCRonline @ ESC Congress 2023: the interventional cardiology perspective!

07 Aug 2023

What was new and hot in interventional cardiology at #ESCCongress 2023!

PCRonline @ ESC Congress 2023